Clinical Trial Update: Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of HSK39297 tablets in lupus nephritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• HSK39297

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Lupus Nephritis (LN) | Phase 2 | Status: RECRUITING